Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samanta Salvi

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Oncotarget|December 29, 2016
Vitamin D status among long-term survivors of testicular cancerGiuseppe Schepisi, Silvia De Padova, Emanuela Scarpi, et al.
Frontiers in Molecular Biosciences|November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerErika Bandini, Tania Rossi, Emanuela Scarpi, et al.
Scientific Reports|October 20, 2018
Plasma androgen receptor and serum chromogranin A in advanced prostate cancerVincenza Conteduca, Emanuela Scarpi, Samanta Salvi, et al.
The Prostate|April 22, 2017
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abirateroneVincenza Conteduca, Orazio Caffo, Cristian Lolli, et al.
Urologic Oncology|February 7, 2018
Association among metabolic syndrome, inflammation, and survival in prostate cancerVincenza Conteduca, Orazio Caffo, Luca Galli, et al.
The Journal of Clinical Investigation|March 10, 2020
Genome-wide plasma DNA methylation features of metastatic prostate cancerAnjui Wu, Paolo Cremaschi, Daniel Wetterskog, et al.
Science Translational Medicine|November 6, 2015
Plasma AR and abiraterone-resistant prostate cancerAlessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancerVincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
European Urology|February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate CancerVincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.
Nature Communications|November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Oncotarget|December 29, 2016
Vitamin D status among long-term survivors of testicular cancerGiuseppe Schepisi, Silvia De Padova, Emanuela Scarpi, et al.
Frontiers in Molecular Biosciences|November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerErika Bandini, Tania Rossi, Emanuela Scarpi, et al.
Scientific Reports|October 20, 2018
Plasma androgen receptor and serum chromogranin A in advanced prostate cancerVincenza Conteduca, Emanuela Scarpi, Samanta Salvi, et al.
The Prostate|April 22, 2017
Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abirateroneVincenza Conteduca, Orazio Caffo, Cristian Lolli, et al.
Urologic Oncology|February 7, 2018
Association among metabolic syndrome, inflammation, and survival in prostate cancerVincenza Conteduca, Orazio Caffo, Luca Galli, et al.
The Journal of Clinical Investigation|March 10, 2020
Genome-wide plasma DNA methylation features of metastatic prostate cancerAnjui Wu, Paolo Cremaschi, Daniel Wetterskog, et al.
Science Translational Medicine|November 6, 2015
Plasma AR and abiraterone-resistant prostate cancerAlessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancerVincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
European Urology|February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate CancerVincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.
Nature Communications|November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Pageof 5